911 related articles for article (PubMed ID: 12193567)
21. Processing of proglucagon to GLP-1 in pancreatic α-cells: is this a paracrine mechanism enabling GLP-1 to act on β-cells?
Whalley NM; Pritchard LE; Smith DM; White A
J Endocrinol; 2011 Oct; 211(1):99-106. PubMed ID: 21795304
[TBL] [Abstract][Full Text] [Related]
22. Mutations to the third cytoplasmic domain of the glucagon-like peptide 1 (GLP-1) receptor can functionally uncouple GLP-1-stimulated insulin secretion in HIT-T15 cells.
Salapatek AM; MacDonald PE; Gaisano HY; Wheeler MB
Mol Endocrinol; 1999 Aug; 13(8):1305-17. PubMed ID: 10446905
[TBL] [Abstract][Full Text] [Related]
23. Glucagon-like peptide 1 inhibits cell apoptosis and improves glucose responsiveness of freshly isolated human islets.
Farilla L; Bulotta A; Hirshberg B; Li Calzi S; Khoury N; Noushmehr H; Bertolotto C; Di Mario U; Harlan DM; Perfetti R
Endocrinology; 2003 Dec; 144(12):5149-58. PubMed ID: 12960095
[TBL] [Abstract][Full Text] [Related]
24. Anti-diabetic actions of glucagon-like peptide-1 on pancreatic beta-cells.
Lee YS; Jun HS
Metabolism; 2014 Jan; 63(1):9-19. PubMed ID: 24140094
[TBL] [Abstract][Full Text] [Related]
25. Elimination of glucagon-like peptide 1R signaling does not modify weight gain and islet adaptation in mice with combined disruption of leptin and GLP-1 action.
Scrocchi LA; Hill ME; Saleh J; Perkins B; Drucker DJ
Diabetes; 2000 Sep; 49(9):1552-60. PubMed ID: 10969840
[TBL] [Abstract][Full Text] [Related]
26. Glucagon-like peptide-1 causes pancreatic duodenal homeobox-1 protein translocation from the cytoplasm to the nucleus of pancreatic beta-cells by a cyclic adenosine monophosphate/protein kinase A-dependent mechanism.
Wang X; Zhou J; Doyle ME; Egan JM
Endocrinology; 2001 May; 142(5):1820-7. PubMed ID: 11316746
[TBL] [Abstract][Full Text] [Related]
27. Glucose-dependent insulinotropic polypeptide is expressed in pancreatic islet alpha-cells and promotes insulin secretion.
Fujita Y; Wideman RD; Asadi A; Yang GK; Baker R; Webber T; Zhang T; Wang R; Ao Z; Warnock GL; Kwok YN; Kieffer TJ
Gastroenterology; 2010 May; 138(5):1966-75. PubMed ID: 20138041
[TBL] [Abstract][Full Text] [Related]
28. Glucagon-like peptide-1 induces a cAMP-dependent increase of [Na+]i associated with insulin secretion in pancreatic beta-cells.
Miura Y; Matsui H
Am J Physiol Endocrinol Metab; 2003 Nov; 285(5):E1001-9. PubMed ID: 14534075
[TBL] [Abstract][Full Text] [Related]
29. Peptones stimulate both the secretion of the incretin hormone glucagon-like peptide 1 and the transcription of the proglucagon gene.
Cordier-Bussat M; Bernard C; Levenez F; Klages N; Laser-Ritz B; Philippe J; Chayvialle JA; Cuber JC
Diabetes; 1998 Jul; 47(7):1038-45. PubMed ID: 9648826
[TBL] [Abstract][Full Text] [Related]
30. Glucagon-like peptide-1 affects gene transcription and messenger ribonucleic acid stability of components of the insulin secretory system in RIN 1046-38 cells.
Wang Y; Egan JM; Raygada M; Nadiv O; Roth J; Montrose-Rafizadeh C
Endocrinology; 1995 Nov; 136(11):4910-7. PubMed ID: 7588224
[TBL] [Abstract][Full Text] [Related]
31. Activation of proglucagon gene transcription by protein kinase-A in a novel mouse enteroendocrine cell line.
Drucker DJ; Jin T; Asa SL; Young TA; Brubaker PL
Mol Endocrinol; 1994 Dec; 8(12):1646-55. PubMed ID: 7535893
[TBL] [Abstract][Full Text] [Related]
32. Identification of glucagon-like peptide 1 (GLP-1) actions essential for glucose homeostasis in mice with disruption of GLP-1 receptor signaling.
Scrocchi LA; Marshall BA; Cook SM; Brubaker PL; Drucker DJ
Diabetes; 1998 Apr; 47(4):632-9. PubMed ID: 9568697
[TBL] [Abstract][Full Text] [Related]
33. NFAT regulates insulin gene promoter activity in response to synergistic pathways induced by glucose and glucagon-like peptide-1.
Lawrence MC; Bhatt HS; Easom RA
Diabetes; 2002 Mar; 51(3):691-8. PubMed ID: 11872668
[TBL] [Abstract][Full Text] [Related]
34. Treatment of type 2 diabetes mellitus with agonists of the GLP-1 receptor or DPP-IV inhibitors.
Holst JJ
Expert Opin Emerg Drugs; 2004 May; 9(1):155-66. PubMed ID: 15155141
[TBL] [Abstract][Full Text] [Related]
35. Regulation of proglucagon transcription by activated transcription factor (ATF) 3 and a novel isoform, ATF3b, through the cAMP-response element/ATF site of the proglucagon gene promoter.
Wang J; Cao Y; Steiner DF
J Biol Chem; 2003 Aug; 278(35):32899-904. PubMed ID: 12815047
[TBL] [Abstract][Full Text] [Related]
36. cAMP-dependent mobilization of intracellular Ca2+ stores by activation of ryanodine receptors in pancreatic beta-cells. A Ca2+ signaling system stimulated by the insulinotropic hormone glucagon-like peptide-1-(7-37).
Holz GG; Leech CA; Heller RS; Castonguay M; Habener JF
J Biol Chem; 1999 May; 274(20):14147-56. PubMed ID: 10318832
[TBL] [Abstract][Full Text] [Related]
37. Glucagon-like peptide-1 and islet lipolysis.
Sörhede Winzell M; Ahrén B
Horm Metab Res; 2004; 36(11-12):795-803. PubMed ID: 15655711
[TBL] [Abstract][Full Text] [Related]
38. POU domain transcription factor brain 4 confers pancreatic alpha-cell-specific expression of the proglucagon gene through interaction with a novel proximal promoter G1 element.
Hussain MA; Lee J; Miller CP; Habener JF
Mol Cell Biol; 1997 Dec; 17(12):7186-94. PubMed ID: 9372951
[TBL] [Abstract][Full Text] [Related]
39. Glucagon-like peptide 1 stimulates insulin gene promoter activity by protein kinase A-independent activation of the rat insulin I gene cAMP response element.
Skoglund G; Hussain MA; Holz GG
Diabetes; 2000 Jul; 49(7):1156-64. PubMed ID: 10909973
[TBL] [Abstract][Full Text] [Related]
40. Bioactive GLP-1 in gut, receptor expression in pancreas, and insulin response to GLP-1 in diabetes-prone rats.
Valverde I; Wang GS; Burghardt K; Kauri LM; Redondo A; Acitores A; Villanueva-Peñacarrillo ML; Courtois P; Sener A; Cancelas J; Malaisse WJ; Scott FW
Endocrine; 2004 Feb; 23(1):77-84. PubMed ID: 15034199
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]